Logo image of RYAM

RAYONIER ADVANCED MATERIALS (RYAM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:RYAM - US75508B1044 - Common Stock

6.53 USD
+0.01 (+0.15%)
Last: 11/28/2025, 7:59:47 PM
6.53 USD
0 (0%)
After Hours: 11/28/2025, 7:59:47 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RYAM. RYAM was compared to 81 industry peers in the Chemicals industry. RYAM has a bad profitability rating. Also its financial health evaluation is rather negative. RYAM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year RYAM has reported negative net income.
In the past year RYAM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: RYAM reported negative net income in multiple years.
Each year in the past 5 years RYAM had a positive operating cash flow.
RYAM Yearly Net Income VS EBIT VS OCF VS FCFRYAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

RYAM has a Return On Assets of -23.14%. This is amonst the worse of the industry: RYAM underperforms 88.89% of its industry peers.
With a Return On Equity value of -122.88%, RYAM is not doing good in the industry: 90.12% of the companies in the same industry are doing better.
The Return On Invested Capital of RYAM (0.63%) is worse than 77.78% of its industry peers.
RYAM had an Average Return On Invested Capital over the past 3 years of 1.78%. This is below the industry average of 6.07%.
Industry RankSector Rank
ROA -23.14%
ROE -122.88%
ROIC 0.63%
ROA(3y)-2.37%
ROA(5y)-0.88%
ROE(3y)-6.96%
ROE(5y)-2.53%
ROIC(3y)1.78%
ROIC(5y)N/A
RYAM Yearly ROA, ROE, ROICRYAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Operating Margin of RYAM (0.76%) is worse than 77.78% of its industry peers.
RYAM has a worse Gross Margin (8.07%) than 86.42% of its industry peers.
In the last couple of years the Gross Margin of RYAM has grown nicely.
Industry RankSector Rank
OM 0.76%
PM (TTM) N/A
GM 8.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.16%
GM growth 5Y22.12%
RYAM Yearly Profit, Operating, Gross MarginsRYAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RYAM is destroying value.
The number of shares outstanding for RYAM has been increased compared to 1 year ago.
The number of shares outstanding for RYAM has been increased compared to 5 years ago.
RYAM has a better debt/assets ratio than last year.
RYAM Yearly Shares OutstandingRYAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RYAM Yearly Total Debt VS Total AssetsRYAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

RYAM has an Altman-Z score of 1.11. This is a bad value and indicates that RYAM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.11, RYAM is doing worse than 72.84% of the companies in the same industry.
RYAM has a Debt/Equity ratio of 2.26. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.26, RYAM is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACC0.05
WACC11.65%
RYAM Yearly LT Debt VS Equity VS FCFRYAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

RYAM has a Current Ratio of 1.57. This is a normal value and indicates that RYAM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.57, RYAM is doing worse than 70.37% of the companies in the same industry.
RYAM has a Quick Ratio of 1.57. This is a bad value and indicates that RYAM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.89, RYAM is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.89
RYAM Yearly Current Assets VS Current LiabilitesRYAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for RYAM have decreased strongly by -234.97% in the last year.
RYAM shows a decrease in Revenue. In the last year, the revenue decreased by -9.75%.
The Revenue has been growing slightly by 2.64% on average over the past years.
EPS 1Y (TTM)-234.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y5.02%
Revenue growth 5Y2.64%
Sales Q2Q%-11.97%

3.2 Future

The Earnings Per Share is expected to grow by 194.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, RYAM will show a small growth in Revenue. The Revenue will grow by 0.30% on average per year.
EPS Next Y-12272.6%
EPS Next 2Y193.19%
EPS Next 3Y194.97%
EPS Next 5YN/A
Revenue Next Year-10.38%
Revenue Next 2Y-3.16%
Revenue Next 3Y0.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RYAM Yearly Revenue VS EstimatesRYAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
RYAM Yearly EPS VS EstimatesRYAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RYAM. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 19.80, RYAM is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as RYAM.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, RYAM is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 19.8
RYAM Price Earnings VS Forward Price EarningsRYAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

RYAM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. RYAM is cheaper than 70.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.12
RYAM Per share dataRYAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

RYAM's earnings are expected to grow with 194.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y193.19%
EPS Next 3Y194.97%

0

5. Dividend

5.1 Amount

No dividends for RYAM!.
Industry RankSector Rank
Dividend Yield N/A

RAYONIER ADVANCED MATERIALS

NYSE:RYAM (11/28/2025, 7:59:47 PM)

After market: 6.53 0 (0%)

6.53

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-05 2026-03-05/amc
Inst Owners71.63%
Inst Owner Change-5.97%
Ins Owners4.76%
Ins Owner Change1.13%
Market Cap437.58M
Revenue(TTM)1.47B
Net Income(TTM)-415.59M
Analysts82.86
Price Target9.18 (40.58%)
Short Float %3.28%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1255.02%
Min EPS beat(2)-2198.35%
Max EPS beat(2)-311.68%
EPS beat(4)1
Avg EPS beat(4)-815.84%
Min EPS beat(4)-2198.35%
Max EPS beat(4)47.48%
EPS beat(8)3
Avg EPS beat(8)-669.57%
EPS beat(12)4
Avg EPS beat(12)-461.74%
EPS beat(16)6
Avg EPS beat(16)-346.36%
Revenue beat(2)0
Avg Revenue beat(2)-10.46%
Min Revenue beat(2)-13.53%
Max Revenue beat(2)-7.39%
Revenue beat(4)0
Avg Revenue beat(4)-8.19%
Min Revenue beat(4)-13.53%
Max Revenue beat(4)-0.8%
Revenue beat(8)2
Avg Revenue beat(8)-5.77%
Revenue beat(12)4
Avg Revenue beat(12)-4.11%
Revenue beat(16)6
Avg Revenue beat(16)-3.05%
PT rev (1m)50%
PT rev (3m)50%
EPS NQ rev (1m)-31.23%
EPS NQ rev (3m)-143.75%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)-910.83%
Revenue NQ rev (1m)-4.72%
Revenue NQ rev (3m)-4.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.8
P/S 0.3
P/FCF N/A
P/OCF 9.39
P/B 1.29
P/tB 1.31
EV/EBITDA 8.12
EPS(TTM)-6.13
EYN/A
EPS(NY)0.33
Fwd EY5.05%
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)0.7
OCFY10.64%
SpS21.96
BVpS5.05
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.14%
ROE -122.88%
ROCE 0.79%
ROIC 0.63%
ROICexc 0.66%
ROICexgc 0.66%
OM 0.76%
PM (TTM) N/A
GM 8.07%
FCFM N/A
ROA(3y)-2.37%
ROA(5y)-0.88%
ROE(3y)-6.96%
ROE(5y)-2.53%
ROIC(3y)1.78%
ROIC(5y)N/A
ROICexc(3y)1.92%
ROICexc(5y)N/A
ROICexgc(3y)1.93%
ROICexgc(5y)N/A
ROCE(3y)2.25%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.16%
GM growth 5Y22.12%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Debt/EBITDA 5.38
Cap/Depr 97.08%
Cap/Sales 8.63%
Interest Coverage 0.14
Cash Conversion 32.79%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.89
Altman-Z 1.11
F-Score4
WACC11.65%
ROIC/WACC0.05
Cap/Depr(3y)90.86%
Cap/Depr(5y)78.47%
Cap/Sales(3y)7.48%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-234.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y-12272.6%
EPS Next 2Y193.19%
EPS Next 3Y194.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y5.02%
Revenue growth 5Y2.64%
Sales Q2Q%-11.97%
Revenue Next Year-10.38%
Revenue Next 2Y-3.16%
Revenue Next 3Y0.3%
Revenue Next 5YN/A
EBIT growth 1Y-85.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year366.46%
EBIT Next 3Y108.2%
EBIT Next 5YN/A
FCF growth 1Y-430.79%
FCF growth 3Y-11.5%
FCF growth 5YN/A
OCF growth 1Y-67.55%
OCF growth 3Y-4.42%
OCF growth 5Y37.19%

RAYONIER ADVANCED MATERIALS / RYAM FAQ

What is the fundamental rating for RYAM stock?

ChartMill assigns a fundamental rating of 2 / 10 to RYAM.


What is the valuation status for RYAM stock?

ChartMill assigns a valuation rating of 2 / 10 to RAYONIER ADVANCED MATERIALS (RYAM). This can be considered as Overvalued.


How profitable is RAYONIER ADVANCED MATERIALS (RYAM) stock?

RAYONIER ADVANCED MATERIALS (RYAM) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for RYAM stock?

The Earnings per Share (EPS) of RAYONIER ADVANCED MATERIALS (RYAM) is expected to decline by -12272.6% in the next year.